“The country has to set up 10 precision medical centers, and Huada has applied for one.†During the 2015 Shenzhen International BT Leaders Summit, Wang Jian, chairman of Huada Gene, said. At the end of January this year, US President Barack Obama proposed the "Precision Medical Care " program in his State of the Union speech. Since then, the US multi-sector has published a detailed response to the Precision Medical Program: FDA plans to establish a platform called “precision FDA†to provide researchers and next-generation sequencing technology developers with cloud tools for storing and sharing genetic information; Not long ago, the head of the National Institutes of Health (NIH), Francis Collins, announced that NIH will begin collecting genetic information for up to 1 million Americans: At the same time, the term precision medicine has also caused great repercussions in China. According to reports, the National Health and Family Planning Commission and the Ministry of Science and Technology have held several meetings to demonstrate and launch the "precise medical" program, and to invest 60 billion yuan in precision medicine by 2030. Accurate medical treatment is even expected to be included in the national “13th Five-Year Plan†for the development of science and technology. The precision medical center disclosed by Wang Jian will also be the beginning of the implementation of the precise medical plan in China. "China has few leading developments in the past developmental state, and it is all follow-up. We have not followed people in recent years, and we are holding others," Wang Jian pointed out that the Chinese gene was raised three years ago. Three million plans (including millions of birth defects, millions of tumors, millions of cardiovascular diseases, etc.), "But unfortunately, we are only civil screams, the United States is led by government action." As the world's largest sequencing company, Huada's ambitions are not limited to the genetic field. At this year's Shenzhen International BT Leaders Summit, Huada Gene announced an incubator, which is jointly invested by Songhe Capital and Tongchuang Weiye. The rainbow is officially launched. According to Liu Wei, founding partner and co-CEO of Blue Rainbow, Blue Rainbow will connect upstream Huada genes, scientific research institutions, and entrepreneurs in various downstream industries to realize the industrialization and commercial application of scientific research results. Left: Blue Rainbow founding partner and co-CEO Liu Wei right: Wang Jian, Chairman of Huada Gene The agency plans to invest in 20 life science start-ups each year, with a first-tier domestic first-tier city and Silicon Valley and Boston. In addition to providing funds for entrepreneurs, Blue Rainbow will also share the core data resources of the genetic industry from three levels: individual first-hand data; feature data, that is, common feature information extracted from the same type of people; and application-level data. . “Hua Da will provide basic platform resources and lower the threshold for entrepreneurship. We are open to such an ecosystem and welcome everyone to start a business together,†added Liu Wei. In addition, the transportation industry talent is another highlight of the blue rainbow incubator. At present, the demand for genetic counselors and bioinformatics analysts has reached one million, and the supply of only 100,000 talents in the whole industry. Liu Wei said that Huada hopes to fill this gap with the help of the genetic talent college in the first phase. At the same time, he also mentioned that a large number of IT talents will be introduced in the future for cross-industry integration. Anal Dildos,Anal Plug Dildo Toys For Women,Anal Plug Dildo Toys For Men,Anal Butt Plug Stimulation Vibrator Shenzhen Dongchen Hey E-commerce Co.,Ltd. , https://www.xxsexytoy.com